Results for tag: "MERS Drug"

The MERS Drug market is a subset of the larger Respiratory Drugs market. It is composed of drugs used to treat Middle East Respiratory Syndrome (MERS), a viral respiratory illness caused by a coronavirus. MERS drugs are typically antiviral medications, such as ribavirin, interferon, and lopinavir/ritonavir, which are used to reduce the severity of symptoms and shorten the duration of the illness. Other drugs, such as corticosteroids, may also be used to reduce inflammation in the lungs. The MERS Drug market is highly competitive, with many companies offering similar products. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Sanofi, Pfizer, and Novartis. Other companies, such as Cipla, Mylan, and Teva Pharmaceuticals, also offer MERS drugs. Show Less Read more